Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 528

1.

Anterior Hippocampal-Cortical Functional Connectivity Distinguishes Antipsychotic Naïve First-Episode Psychosis Patients From Controls and May Predict Response to Second-Generation Antipsychotic Treatment.

Blessing EM, Murty VP, Zeng B, Wang J, Davachi L, Goff DC.

Schizophr Bull. 2019 Aug 21. pii: sbz076. doi: 10.1093/schbul/sbz076. [Epub ahead of print]

PMID:
31433843
2.

Targeted Treatment of Individuals With Psychosis Carrying a Copy Number Variant Containing a Genomic Triplication of the Glycine Decarboxylase Gene.

Bodkin JA, Coleman MJ, Godfrey LJ, Carvalho CMB, Morgan CJ, Suckow RF, Anderson T, Öngür D, Kaufman MJ, Lewandowski KE, Siegel AJ, Waldstreicher E, Grochowski CM, Javitt DC, Rujescu D, Hebbring S, Weinshilboum R, Rodriguez SB, Kirchhoff C, Visscher T, Vuckovic A, Fialkowski A, McCarthy S, Malhotra D, Sebat J, Goff DC, Hudson JI, Lupski JR, Coyle JT, Rudolph U, Levy DL.

Biol Psychiatry. 2019 Oct 1;86(7):523-535. doi: 10.1016/j.biopsych.2019.04.031. Epub 2019 May 9.

PMID:
31279534
3.

Cannabis Use and Markers of Systemic Inflammation: The Coronary Artery Risk Development in Young Adults Study.

Alshaarawy O, Sidney S, Auer R, Green D, Soliman EZ, Goff DC Jr, Anthony JC.

Am J Med. 2019 May 29. pii: S0002-9343(19)30442-5. doi: 10.1016/j.amjmed.2019.04.045. [Epub ahead of print]

PMID:
31150645
4.

Implementing the National Heart, Lung, and Blood Institute's Strategic Vision in the Division of Cardiovascular Sciences.

Writing Group for the Division of Cardiovascular Sciences’ Strategic Vision Implementation Plan, Goff DC Jr, Buxton DB, Pearson GD, Wei GS, Gosselin TE, Addou EA, Stoney CM, Desvigne-Nickens P, Srinivas PR, Galis ZS, Pratt C, Kit KBK, Maric-Bilkan C, Nicastro HL, Wong RP, Sachdev V, Chen J, Fine L.

Circ Res. 2019 Feb 15;124(4):491-497. doi: 10.1161/CIRCRESAHA.118.314338.

PMID:
31031412
5.

The National Heart, Lung, and Blood Institute Strategic Vision Implementation for Health Equity Research.

Mensah GA, Stoney CM, Freemer MM, Smith S, Engelgau MM, Hoots WK, Kiley JP, Goff DC.

Ethn Dis. 2019 Feb 21;29(Suppl 1):57-64. doi: 10.18865/ed.29.S1.57. eCollection 2019.

6.

Can Adjunctive Pharmacotherapy Reduce Hospitalization in Schizophrenia?: Insights From Administrative Databases.

Goff DC.

JAMA Psychiatry. 2019 May 1;76(5):468-470. doi: 10.1001/jamapsychiatry.2018.4318. No abstract available.

PMID:
30785617
7.

Racial Differences in Maintaining Optimal Health Behaviors Into Middle Age.

Booth JN 3rd, Allen NB, Calhoun D, Carson AP, Deng L, Goff DC Jr, Redden DT, Reis JP, Shimbo D, Shikany JM, Sidney S, Spring B, Lewis CE, Muntner P.

Am J Prev Med. 2019 Mar;56(3):368-375. doi: 10.1016/j.amepre.2018.10.020.

PMID:
30777156
8.

Adjunctive telmisartan treatment on body metabolism in clozapine or olanzapine treated patients with schizophrenia: a randomized, double blind, placebo controlled trial.

Fan X, Copeland P, Nawras S, Harrington A, Freudenreich O, Goff DC, Henderson DC.

Psychopharmacology (Berl). 2019 Jun;236(6):1949-1957. doi: 10.1007/s00213-019-5181-z. Epub 2019 Feb 12.

PMID:
30747254
9.

Cigarette smoking and gray matter brain volumes in middle age adults: the CARDIA Brain MRI sub-study.

Elbejjani M, Auer R, Jacobs DR Jr, Haight T, Davatzikos C, Goff DC Jr, Bryan RN, Launer LJ.

Transl Psychiatry. 2019 Feb 11;9(1):78. doi: 10.1038/s41398-019-0401-1.

10.

Citalopram in first episode schizophrenia: The DECIFER trial.

Goff DC, Freudenreich O, Cather C, Holt D, Bello I, Diminich E, Tang Y, Ardekani BA, Worthington M, Zeng B, Wu R, Fan X, Li C, Troxel A, Wang J, Zhao J.

Schizophr Res. 2019 Jun;208:331-337. doi: 10.1016/j.schres.2019.01.028. Epub 2019 Jan 30.

11.

Association Between Alcohol Intake and Cardiac Remodeling.

Rodrigues P, Santos-Ribeiro S, Teodoro T, Gomes FV, Leal I, Reis JP, Goff DC Jr, Gonçalves A, Lima JAC.

J Am Coll Cardiol. 2018 Sep 25;72(13):1452-1462. doi: 10.1016/j.jacc.2018.07.050.

PMID:
30236306
12.

Association of Patterns of Change in Adiposity With Diastolic Function and Systolic Myocardial Mechanics From Early Adulthood to Middle Age: The Coronary Artery Risk Development in Young Adults Study.

Khan SS, Shah SJ, Colangelo LA, Panjwani A, Liu K, Lewis CE, Shay CM, Goff DC Jr, Reis J, Vasconcellos HD, Lima JAC, Lloyd-Jones D, Allen NB.

J Am Soc Echocardiogr. 2018 Dec;31(12):1261-1269.e8. doi: 10.1016/j.echo.2018.07.014. Epub 2018 Sep 1.

PMID:
30181008
13.

Predicting Cardiovascular Health in Coronary Artery Risk Development in Young Adults.

Gooding HC, Ning H, Gillman MW, Allen N, Goff DC Jr, Rana JS, Chiuve S, Lloyd-Jones DM.

J Am Coll Cardiol. 2018 Jun 5;71(22):2601-2602. doi: 10.1016/j.jacc.2018.01.082. No abstract available.

14.

Blood Pressure Control-Much Has Been Achieved, Much Remains to Be Done.

Fine LJ, Goff DC, Mensah GA.

JAMA Cardiol. 2018 Jul 1;3(7):555-556. doi: 10.1001/jamacardio.2018.1259. No abstract available.

PMID:
29800015
15.

Racial Disparities in Cardiovascular Health Behaviors: The Coronary Artery Risk Development in Young Adults Study.

Whitaker KM, Jacobs DR Jr, Kershaw KN, Demmer RT, Booth JN 3rd, Carson AP, Lewis CE, Goff DC Jr, Lloyd-Jones DM, Gordon-Larsen P, Kiefe CI.

Am J Prev Med. 2018 Jul;55(1):63-71. doi: 10.1016/j.amepre.2018.03.017. Epub 2018 Jun 18.

16.

Association between catechol-O-methyltransferase genetic variation and functional connectivity in patients with first-episode schizophrenia.

Wang H, Zhang B, Zeng B, Tang Y, Zhang T, Zhao S, Li C, Wang J, Goff DC.

Schizophr Res. 2018 Sep;199:214-220. doi: 10.1016/j.schres.2018.04.023. Epub 2018 May 3.

PMID:
29730044
17.

Blood pressure-lowering treatment strategies based on cardiovascular risk versus blood pressure: A meta-analysis of individual participant data.

Karmali KN, Lloyd-Jones DM, van der Leeuw J, Goff DC Jr, Yusuf S, Zanchetti A, Glasziou P, Jackson R, Woodward M, Rodgers A, Neal BC, Berge E, Teo K, Davis BR, Chalmers J, Pepine C, Rahimi K, Sundström J; Blood Pressure Lowering Treatment Trialists’ Collaboration.

PLoS Med. 2018 Mar 20;15(3):e1002538. doi: 10.1371/journal.pmed.1002538. eCollection 2018 Mar.

18.

Reis et al. Respond.

Reis JP, Auer R, Bancks MP, Goff DC Jr, Lewis CE, Pletcher MJ, Rana JS, Shikany JM, Sidney S.

Am J Public Health. 2018 Apr;108(4):e12. doi: 10.2105/AJPH.2018.304308. No abstract available.

PMID:
29513576
19.

Association of Hippocampal Atrophy With Duration of Untreated Psychosis and Molecular Biomarkers During Initial Antipsychotic Treatment of First-Episode Psychosis.

Goff DC, Zeng B, Ardekani BA, Diminich ED, Tang Y, Fan X, Galatzer-Levy I, Li C, Troxel AB, Wang J.

JAMA Psychiatry. 2018 Apr 1;75(4):370-378. doi: 10.1001/jamapsychiatry.2017.4595.

20.

Optimizing the Pharmacologic Treatment of Individuals With First-Episode Psychosis.

Goff DC.

Am J Psychiatry. 2018 Feb 1;175(2):101-102. doi: 10.1176/appi.ajp.2017.17101126. No abstract available.

PMID:
29385823

Supplemental Content

Loading ...
Support Center